Thomas Starkey

2.7k total citations
10 papers, 159 citations indexed

About

Thomas Starkey is a scholar working on Oncology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Thomas Starkey has authored 10 papers receiving a total of 159 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Infectious Diseases and 2 papers in Molecular Biology. Recurrent topics in Thomas Starkey's work include COVID-19 and healthcare impacts (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and COVID-19 Clinical Research Studies (3 papers). Thomas Starkey is often cited by papers focused on COVID-19 and healthcare impacts (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and COVID-19 Clinical Research Studies (3 papers). Thomas Starkey collaborates with scholars based in United Kingdom, Italy and United States. Thomas Starkey's co-authors include Lennard Y. W. Lee, Alex Richter, Antonio Pagliuca, Stefania Segditsas, Chiara Bardella, Michaël Tilby, Sujata Biswas, Shazia Irshad, Ian Tomlinson and Gary Middleton and has published in prestigious journals such as Clinical Cancer Research, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Thomas Starkey

10 papers receiving 158 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Starkey United Kingdom 6 93 40 37 31 21 10 159
Changxin Shen China 7 104 1.1× 28 0.7× 32 0.9× 19 0.6× 11 0.5× 11 166
Youchao Dai China 5 123 1.3× 42 1.1× 41 1.1× 5 0.2× 16 0.8× 9 184
Jacob Kinskey United States 4 107 1.2× 34 0.8× 5 0.1× 41 1.3× 34 1.6× 7 172
Hilary Racher Canada 5 69 0.7× 12 0.3× 30 0.8× 25 0.8× 4 0.2× 9 111
Rachael N. McVicar United States 5 52 0.6× 46 1.1× 15 0.4× 16 0.5× 10 0.5× 7 124
Joanna Jarkiewicz‐Tretyn Poland 6 69 0.7× 33 0.8× 4 0.1× 16 0.5× 11 0.5× 12 137
Sydney Stein United States 6 52 0.6× 43 1.1× 6 0.2× 7 0.2× 42 2.0× 9 139
Xiangyang Yao China 8 66 0.7× 31 0.8× 8 0.2× 6 0.2× 14 0.7× 18 125
Haiming Kou China 5 18 0.2× 27 0.7× 23 0.6× 70 2.3× 23 1.1× 17 113
Melissa Ng Singapore 6 25 0.3× 23 0.6× 5 0.1× 25 0.8× 64 3.0× 10 149

Countries citing papers authored by Thomas Starkey

Since Specialization
Citations

This map shows the geographic impact of Thomas Starkey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Starkey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Starkey more than expected).

Fields of papers citing papers by Thomas Starkey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Starkey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Starkey. The network helps show where Thomas Starkey may publish in the future.

Co-authorship network of co-authors of Thomas Starkey

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Starkey. A scholar is included among the top collaborators of Thomas Starkey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Starkey. Thomas Starkey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Dong, Jiawen, Thomas Starkey, Vinton W.T. Cheng, et al.. (2025). Impact of GLP-1 receptor agonist-induced weight loss on 22 cancers in the next ten years using a Markov state-transition model – A UK weight and wellness cancer landscape analysis. Cancer Epidemiology. 97. 102837–102837. 1 indexed citations
2.
Starkey, Thomas, et al.. (2023). Systematic review and meta‐analysis of the clinical effectiveness of tixagevimab/cilgavimab for prophylaxis of COVID‐19 in immunocompromised patients. British Journal of Haematology. 201(5). 813–823. 23 indexed citations
3.
Starkey, Thomas, et al.. (2022). Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic review. British Journal of Cancer. 127(10). 1827–1836. 14 indexed citations
4.
Starkey, Thomas, et al.. (2021). A systematic review of the sensitivity and specificity of lateral flow devices in the detection of SARS-CoV-2. BMC Infectious Diseases. 21(1). 828–828. 73 indexed citations
5.
6.
Lee, Lennard Y. W., Jean‐Baptiste Cazier, Thomas Starkey, et al.. (2020). COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. UCL Discovery (University College London). 4 indexed citations
7.
Starkey, Thomas, et al.. (2020). 1677MO COVID-19 mortality in hospitalized cancer patients is not significantly affected by chemotherapy or other anti-cancer treatments. Annals of Oncology. 31. S994–S995. 1 indexed citations
8.
Pickles, Oliver, Lennard Y. W. Lee, Thomas Starkey, et al.. (2020). Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?. British Journal of Cancer. 123(5). 691–693. 12 indexed citations
9.
Lee, Lennard Y. W., Thomas Starkey, Shivan Sivakumar, et al.. (2019). ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single‐center clinical utility study—PRECISE study. Cancer Medicine. 8(14). 6305–6314. 6 indexed citations
10.
Lee, Lennard Y. W., Thomas Starkey, Sujata Biswas, et al.. (2018). Serum- and Glucocorticoid-induced Kinase Sgk1 Directly Promotes the Differentiation of Colorectal Cancer Cells and Restrains Metastasis. Clinical Cancer Research. 25(2). 629–640. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026